Outcomes of Nonagenarians With Acute Coronary Syndrome

• Published in: Journal of the American Medical Directors Association Vol. 23; no. 1; pp. 81 - 86.e4
• Main Authors: Cepas-Guillén, Pedro Luis, Echarte-Morales, Julio, Caldentey, Guillem, Gómez, Eduardo Martinez, Flores-Umanzor, Eduardo, Borrego-Rodriguez, Javier, Llagostera, Marc, Viana Tejedor, Ana, Vidal, Pablo, Benito-Gonzalez, Tomás, Quiroga, Xavier, Ortiz, Antonio Fernández, Freixa, Xavier, Pérez de Prado, Armando, Sanz, Francisco Noriega, Fernández-Vázquez, Felipe, Sabate, Manel
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-01-2022
• Subjects: acute coronary syndrome; Acute Coronary Syndrome - therapy; Aged, 80 and over; elderly; Female; Humans; Male; Myocardial Infarction; Nonagenarians; Percutaneous Coronary Intervention; Risk Factors; ST Elevation Myocardial Infarction; ST-segment elevation myocardial infarction; Treatment Outcome; Myocardial infarction; acute coronary syndrome; ST-segment elevation myocardial infarction; nonagenarians; elderly
• ISSN: 1525-8610; 1538-9375
• DOI: 10.1016/j.jamda.2021.04.027

Nonagenarians are a fast-growing age group among cardiovascular patients, but data about their management and prognosis after an acute coronary syndrome (ACS) is scarce. This study aimed to analyze characteristics of nonagenarian patients with ACS and to compare in-hospital and 1-year clinical outcomes between those treated with medical treatment (MT) alone and those receiving percutaneous coronary intervention (PCI).
Multicenter observational study.
We included consecutive nonagenarian patients with ACS admitted at 4 academic centers between 2005 and 2018. Only patients with type 1 myocardial infarction were included.
Standardized definitions of all patient-related variables, clinical diagnoses, and hospital complications and outcomes were used. The primary endpoint was 1-year all-cause mortality. Long-term survival was compared between patients undergoing PCI and those managed with MT alone. Given differences in baseline characteristics could substantially interfere in outcomes, 3 sensitivity analyses were performed to adjust for confounders.
A total of 680 nonagenarians were included (59% females). Of them, 373 (55%) patients presented with non–ST-segment elevation ACS (NSTE-ACS) and 307 (45%) with ST-segment elevation myocardial infarction (STEMI). A coronary angiogram was performed in 115 (31%) of NSTE-ACS and in 182 (60%) of STEMI patients with subsequent PCI in 81 (22%) and 156 (51%), respectively. Overall mortality rates were 17% in-hospital and 39% at 1-year follow-up. PCI was independently associated with a decreased risk of 1-year all-cause death [hazard ratio (HR) 0.57, 95% confidence interval (CI) 0.35, 0.95; P < .05], mainly observed in those patients without disability (HR 0.59, 95% CI 0.37, 0.94; P < .01) and lower Killip class (HR 0.50, 95% CI 0.28, 0.89; P < .001).
The prognosis of nonagenarians after an ACS was associated with comorbidities and the therapeutic approach. Although PCI appeared to be a safe and effective strategy, it is still necessary to refine the decision-making process in this high-risk population group.